Latest news articles

Added 1 year ago Drug news

Phase III ENLIVEN study of CSF 1R shows efficacy and safety in tenosynovial giant cell tumor.- Daiichi Sankyo.

Daiichi Sankyo announced that the phase III ENLIVEN study showed a statistically significant 39 percent overall response rate (ORR) at...

Added 2 years ago Drug news

Improved joint health in haemophilia A patients treated prophylactically with Elocta /Eloctate - SOBI + Bioverativ.

Swedish Orphan Biovitrum AB (publ) (Sobi) and Bioverativ Inc. announce the publication of interim results from a longitudinal study of joint...

Added 6 years ago Drug news

FDA approves Zimmer PSI Shoulder System

Zimmer has received 510(k) clearance from the FDA to market the Zimmer Patient Specific Instruments (PSI) Shoulder system to complement...

Search all news articles for Non-traumatic joint disorders
 

Learning Zones

An epgonline.org Learning Zone (LZ) is an area of the site dedicated to providing detailed self-directed medical education about a disease, condition or procedure.

Optimising anti-TNF treatment using biosimilars

Optimising anti-TNF treatment using biosimilars

Biosimilars are uniquely placed to change clinical practice in the fields of gastroenterology, rheumatology, and dermatology. The adoption of biosimilars can improve patient access to the most appropriate treatment, at the optimum time, to ensure the best possible long-term disease outcomes.

Idiopathic Pulmonary Fibrosis

Idiopathic Pulmonary Fibrosis

Idiopathic pulmonary fibrosis (IPF) is a chronic and progressive fibrotic interstitial lung disease that occurs mostly in older adults, is limited to the lungs and often displays a characteristic imaging and histological appearance. Find out how to diagnose IPF and the latest interventions available for patients living with this burden.

Load more

Guidelines

Guidelines for the management of acute joint bleeds and chronic synovitis in haemophilia: A United Kingdom Haemophilia Centre Doctors' Organisation (UKHCDO) guideline.

Evidence-based guidelines were developed summarizing best practice for the assessment and management of acute joint bleeds and chronic synovitis in persons with haemophilia.

Added 1 year ago

Search all guidelines for Non-traumatic joint disorders
 

Journal articles

Improved joint health in subjects with severe haemophilia A treated prophylactically with recombinant factor VIII Fc fusion protein.

Aim: This study assessed change in joint health over time in subjects receiving recombinant factor VIII Fc fusion protein (rFVIIIFc) prophylaxis.

Added 2 years ago

Hip arthroscopy: Indications, outcomes and complications.

Hip arthroscopy has recently occupied an important place in the armamentarium of General Orthopedic and especially hip surgeons. It is an effective and innovative procedure with rapidly expanding indications.

Added 2 years ago

Ilizarov hip reconstruction osteotomy - A review.

Hip joint instability can be secondary to congenital hip pathologies like developmental dysplasia (DDH) or acquired such as sequel of infective or neoplastic process. An unstable hip is usually associated with loss of bone from...

Added 2 years ago

Search all journal articles for Non-traumatic joint disorders
 

Clinical trials

Phase 3 Study of Pexidartinib for Pigmented Villonodular Synovitis (PVNS) or Giant Cell Tumor of the Tendon Sheath (GCT-TS) (ENLIVEN)

The main purpose of this study is to gather information about the investigational drug pexidartinib, which may help to treat tumors of pigmented villonodular synovitis (PVNS) or giant cell tumor of the tendon sheath (GCT-TS).

Added 1 year ago

Search all clinical trials for Non-traumatic joint disorders
 

CME

Physical impairments in symptomatic femoroacetabular impingement: a systematic review of the evidence

Accrediting body
Union of European Medical Specialists (via European Accreditation Council for CME)
Credits available
1
Registration required
1
Subscription fee
90
Search all CME for Non-traumatic joint disorders